Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

Marlyn J. Mayo, John M. Vierling, Christopher L. Bowlus, Cynthia Levy, Gideon M. Hirschfield, Guy W. Neff, Michael R. Galambos, Stuart C. Gordon, Brian B. Borg, Stephen A. Harrison, Paul J. Thuluvath, Aparna Goel, Mitchell L. Shiffman, Mark G. Swain, David E.J. Jones, Palak Trivedi, Andreas E. Kremer, Richard J. Aspinall, David A. Sheridan, Yvonne DörffelKe Yang, Yun Jung Choi, Charles A. McWherter

Internal Medicine
Int Med - Digestv & Liver Dis

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Sort by
Weight
Alphabetically

Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

Fingerprint

Medicine & Life Sciences